The increase of alumina calcination temperature from 800 °C to 1300 °C results in the transformation of γ-Al2O3 to α-Al2O3 phase accompanying a decrease of specific surface area and the amount of tetrahedral Al3+ sites. Over Ru–Ba/alumina catalysts, an increase in alumina calcination temperature would broaden the size distribution of Ru particles, enlarge the metal-to-oxide ratio of Ru, decrease the amount of surface hydroxyl groups, as well as lower the temperature for N2 desorption. As a result, the increase of alumina calcination temperature lessens the effect of hydrogen poisoning and decreases the activation energy for ammonia synthesis. The Ru–Ba/Al2O3 catalyst with alumina calcined at 980 °C having both θ-Al2O3 and α-Al2O3 shows ammonia synthesis rate three times higher than that with alumina calcined at 800 °C having a γ-Al2O3 phase.

Metal−support interactions strongly affect the catalytic performances of ceriasupported metal catalysts, and hydrogen treatment at high temperature is important for the preparation of catalysts that show strong metal−support interaction (SMSI). With SMSI, the proportion of metal species existing in the form of a metallic state is lowered, consequently hindering the performance of a metal catalyst for a reaction that requires metallic sites. Here we show that CO activation of a Ru/CeO 2 catalyst not only enhances the reduction degree and exposure of Ru species but also increases Ce 3+ concentration, oxygen vacancy (O V ), and active oxygen, resulting in the formation of electron-enriched Ru δ− species and Ru δ− −O V −Ce 3+ sites. As a result, a Ru/CeO 2 catalyst after CO activation shows high ammonia synthesis activity, and the ill effect of hydrogen poisoning is effectively alleviated. These findings are important for the design of supported metal catalysts that afford metallic species as active sites.

The spatial arrangements of Ti species would affect the electronic metal–support interactions and the proportion of Ce3+ sites for ceria-supported Ru catalysts.

No abstract

Safe multifunctional nanoplatforms that have multiple therapeutic functions integrated with imaging capabilities are highly desired for biomedical applications. In this paper, targeted chemo-photothermal synergistic therapy and photoacoustic/computed tomography imaging of tumors were achieved by one novel multifunctional nanoprobe (GMS/DOX@SLB-FA); it was composed of a gold nanostar core and a doxorubicin (DOX)-loaded mesoporous silica shell (GMS), which was coated with a folic acid (FA)-modified thermosensitively supported lipid bilayer (SLB-FA) as a gatekeeper. The multifunctional probe had perfect dispersion and stability; 2.1 nm mesoporous pores and 208 nm hydration particle sizes were obtained. In vitro studies indicated that the drug-loaded probe had excellent ability to control the release of DOX, with 71.98 ± 2.52% cumulative release after laser irradiation, which was significantly higher than that of unirradiated control group. A survival rate of 72.75 ± 4.37% of HeLa cells at 57.75 μg/mL probe also demonstrated the low cytotoxicity of the targeted probe. Both in vitro and in vivo results showed that the probe could achieve targeted photoacoustic imaging of tumors because of the fact that the FA-modified probe could specifically recognize the overexpressed FA receptors on tumor cells; meanwhile, the probe could also achieve the chemo-photothermal synergistic therapy of tumors through controlling the drug release from mesoporous channels by a near-infrared laser. Therefore, the probe had great potential in the early diagnosis and treatment of cancer.